Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-05-05 @ 9:34 AM
Study NCT ID:
NCT02004769
Status:
COMPLETED
Last Update Posted:
2016-11-18
First Post:
2013-09-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer
Sponsor:
Organization: